Modeling and Predicting Antibody Durability for mRNA-1273 Vaccine for SARS-CoV-2 Variants

George Luo, Zhongbo Hu, John J. Letterio
doi: https://doi.org/10.1101/2021.05.04.21256537

Article Information

doi 
https://doi.org/10.1101/2021.05.04.21256537
History 
  • May 4, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. George Luo1,*,
  2. Zhongbo Hu1,2 and
  3. John J. Letterio1,2
  1. 1Case Comprehensive Cancer Center, Cleveland, Ohio, USA
  2. 2The Angie Fowler Adolescent & Young Adult Cancer Institute, University Hospitals Rainbow Babies & Children’s Hospital, Cleveland, Ohio, USA
  1. ↵*Corresponding author: George Luo; gxl263{at}case.edu
Back to top
Posted May 04, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Modeling and Predicting Antibody Durability for mRNA-1273 Vaccine for SARS-CoV-2 Variants
George Luo, Zhongbo Hu, John J. Letterio
medRxiv 2021.05.04.21256537; doi: https://doi.org/10.1101/2021.05.04.21256537
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area